These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A comparison of prodrug esters of nipecotic acid. Hinko CN; Crider AM; Wood JD Neuropharmacology; 1988 May; 27(5):475-83. PubMed ID: 3393269 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, stability, and pharmacological evaluation of nipecotic acid prodrugs. Bonina FP; Arenare L; Palagiano F; Saija A; Nava F; Trombetta D; de Caprariis P J Pharm Sci; 1999 May; 88(5):561-7. PubMed ID: 10229650 [TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Enhanced BBB Penetration Studies of L-serine-Tethered Nipecotic Acid-Prodrug. Dhanawat M; Gupta S; Mehta DK; Das R Drug Res (Stuttg); 2021 Feb; 71(2):94-103. PubMed ID: 33241549 [TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant activity of the nipecotic acid ester, (+/-)-m-nitrophenyl-3-piperidinecarboxylate. Hinko CN; Seibert K; Crider AM Neuropharmacology; 1984 Sep; 23(9):1009-14. PubMed ID: 6549050 [TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, Evaluation and Computational Studies of Nipecotic Acid-Acetonaphthone Hybrids as Potential Antiepileptic Agents. Seth A; Sharma PA; Tripathi A; Choubey PK; Srivastava P; Tripathi PN; Shrivastava SK Med Chem; 2018; 14(4):409-426. PubMed ID: 29336266 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and anticonvulsive activity of analogs of gamma-vinyl GABA. Zhao LX; Park JG; Moon YS; Basnet A; Choi J; Kim EK; Jeong TC; Jahng Y; Lee ES Farmaco; 2004 May; 59(5):381-8. PubMed ID: 15120317 [TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant activity of GABA uptake inhibitors and their prodrugs following central or systemic administration. Croucher MJ; Meldrum BS; Krogsgaard-Larsen P Eur J Pharmacol; 1983 May; 89(3-4):217-28. PubMed ID: 6873158 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity studies on benzhydrol-containing nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptake. Pavia MR; Lobbestael SJ; Nugiel D; Mayhugh DR; Gregor VE; Taylor CP; Schwarz RD; Brahce L; Vartanian MG J Med Chem; 1992 Oct; 35(22):4238-48. PubMed ID: 1433224 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and anticonvulsive activities of potential prodrugs linked by two-carbon chain. Zhao LX; Moon YS; Basnet A; Park JG; Kim EK; Kim DO; Jeong TC; Jahng Y; Choi J; Lee ES Arch Pharm Res; 2003 Oct; 26(10):785-95. PubMed ID: 14609124 [TBL] [Abstract][Full Text] [Related]
12. Kinetic characterization of inhibition of gamma-aminobutyric acid uptake into cultured neurons and astrocytes by 4,4-diphenyl-3-butenyl derivatives of nipecotic acid and guvacine. Larsson OM; Falch E; Krogsgaard-Larsen P; Schousboe A J Neurochem; 1988 Mar; 50(3):818-23. PubMed ID: 3339356 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel GABA uptake inhibitors. 3. Diaryloxime and diarylvinyl ether derivatives of nipecotic acid and guvacine as anticonvulsant agents. Knutsen LJ; Andersen KE; Lau J; Lundt BF; Henry RF; Morton HE; Naerum L; Petersen H; Stephensen H; Suzdak PD; Swedberg MD; Thomsen C; Sørensen PO J Med Chem; 1999 Sep; 42(18):3447-62. PubMed ID: 10479278 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates. Andersen KE; Sørensen JL; Huusfeldt PO; Knutsen LJ; Lau J; Lundt BF; Petersen H; Suzdak PD; Swedberg MD J Med Chem; 1999 Oct; 42(21):4281-91. PubMed ID: 10543872 [TBL] [Abstract][Full Text] [Related]
15. The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate. Andersen KE; Braestrup C; Grønwald FC; Jørgensen AS; Nielsen EB; Sonnewald U; Sørensen PO; Suzdak PD; Knutsen LJ J Med Chem; 1993 Jun; 36(12):1716-25. PubMed ID: 8510100 [TBL] [Abstract][Full Text] [Related]
16. The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy. Smith SE; Parvez NS; Chapman AG; Meldrum BS Eur J Pharmacol; 1995 Feb; 273(3):259-65. PubMed ID: 7737333 [TBL] [Abstract][Full Text] [Related]
17. Investigation of platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids. de Candia M; Summo L; Carrieri A; Altomare C; Nardecchia A; Cellamare S; Carotti A Bioorg Med Chem; 2003 Apr; 11(7):1439-50. PubMed ID: 12628670 [TBL] [Abstract][Full Text] [Related]